4-[2-(difluoromethyl)benzimidazol-1-yl]-N-[1-[2-[3-(dimethylamino)propyl]phenyl]-2-methylpropan-2-yl]-6-morpholin-4-yl-1,3,5-triazin-2-amine;4-[2-(difluoromethyl)benzimidazol-1-yl]-N-(2,3-dimethyl-3-phenylbutan-2-yl)-6-morpholin-4-yl-1,3,5-triazin-2-amine;4-[2-(difluoromethyl)benzimidazol-1-yl]-N-[2-methyl-1-[2-(1-methylpiperidin-4-yl)oxyphenyl]propan-2-yl]-6-morpholin-4-yl-1,3,5-triazin-2-amine;4-[2-(difluoromethyl)benzimidazol-1-yl]-6-morpholin-4-yl-N-[2-(1-phenylcyclopropyl)propan-2-yl]-1,3,5-triazin-2-amine

C115H136F8N30O5 — CID 157433441

IUPAC4-[2-(difluoromethyl)benzimidazol-1-yl]-N-[1-[2-[3-(dimethylamino)propyl]phenyl]-2-methylpropan-2-yl]-6-morpholin-4-yl-1,3,5-triazin-2-amine;4-[2-(difluoromethyl)benzimidazol-1-yl]-N-(2,3-dimethyl-3-phenylbutan-2-yl)-6-morpholin-4-yl-1,3,5-triazin-2-amine;4-[2-(difluoromethyl)benzimidazol-1-yl]-N-[2-methyl-1-[2-(1-methylpiperidin-4-yl)oxyphenyl]propan-2-yl]-6-morpholin-4-yl-1,3,5-triazin-2-amine;4-[2-(difluoromethyl)benzimidazol-1-yl]-6-morpholin-4-yl-N-[2-(1-phenylcyclopropyl)propan-2-yl]-1,3,5-triazin-2-amine
SMILESCC(C)(Nc1nc(N2CCOCC2)nc(-n2c(C(F)F)nc3ccccc32)n1)C(C)(C)c1ccccc1.CC(C)(Nc1nc(N2CCOCC2)nc(-n2c(C(F)F)nc3ccccc32)n1)C1(c2ccccc2)CC1.CN(C)CCCc1ccccc1CC(C)(C)Nc1nc(N2CCOCC2)nc(-n2c(C(F)F)nc3ccccc32)n1.CN1CCC(Oc2ccccc2CC(C)(C)Nc2nc(N3CCOCC3)nc(-n3c(C(F)F)nc4ccccc43)n2)CC1
InChIInChI=1S/C31H38F2N8O2.C30H38F2N8O.C27H29F2N7O.C27H31F2N7O/c1-31(2,20-21-8-4-7-11-25(21)43-22-12-14-39(3)15-13-22)38-28-35-29(40-16-18-42-19-17-40)37-30(36-28)41-24-10-6-5-9-23(24)34-27(41)26(32)33;1-30(2,20-22-11-6-5-10-21(22)12-9-15-38(3)4)37-27-34-28(39-16-18-41-19-17-39)36-29(35-27)40-24-14-8-7-13-23(24)33-26(40)25(31)32;1-26(2,27(12-13-27)18-8-4-3-5-9-18)34-23-31-24(35-14-16-37-17-15-35)33-25(32-23)36-20-11-7-6-10-19(20)30-22(36)21(28)29;1-26(2,18-10-6-5-7-11-18)27(3,4)34-23-31-24(35-14-16-37-17-15-35)33-25(32-23)36-20-13-9-8-12-19(20)30-22(36)21(28)29/h4-11,22,26H,12-20H2,1-3H3,(H,35,36,37,38);5-8,10-11,13-14,25H,9,12,15-20H2,1-4H3,(H,34,35,36,37);3-11,21H,12-17H2,1-2H3,(H,31,32,33,34);5-13,21H,14-17H2,1-4H3,(H,31,32,33,34)
InChIKeyBQUXLDOZLOHMEY-UHFFFAOYSA-N
MW2170.54 g/mol
LogP19.86
Rot. Bonds34

About 4-[2-(difluoromethyl)benzimidazol-1-yl]-N-[1-[2-[3-(dimethylamino)propyl]phenyl]-2-methylpropan-2-yl]-6-morpholin-4-yl-1,3,5-triazin-2-amine;4-[2-(difluoromethyl)benzimidazol-1-yl]-N-(2,3-dimethyl-3-phenylbutan-2-yl)-6-morpholin-4-yl-1,3,5-triazin-2-amine;4-[2-(difluoromethyl)benzimidazol-1-yl]-N-[2-methyl-1-[2-(1-methylpiperidin-4-yl)oxyphenyl]propan-2-yl]-6-morpholin-4-yl-1,3,5-triazin-2-amine;4-[2-(difluoromethyl)benzimidazol-1-yl]-6-morpholin-4-yl-N-[2-(1-phenylcyclopropyl)propan-2-yl]-1,3,5-triazin-2-amine

4-[2-(difluoromethyl)benzimidazol-1-yl]-N-[1-[2-[3-(dimethylamino)propyl]phenyl]-2-methylpropan-2-yl]-6-morpholin-4-yl-1,3,5-triazin-2-amine;4-[2-(difluoromethyl)benzimidazol-1-yl]-N-(2,3-dimethyl-3-phenylbutan-2-yl)-6-morpholin-4-yl-1,3,5-triazin-2-amine;4-[2-(difluoromethyl)benzimidazol-1-yl]-N-[2-methyl-1-[2-(1-methylpiperidin-4-yl)oxyphenyl]propan-2-yl]-6-morpholin-4-yl-1,3,5-triazin-2-amine;4-[2-(difluoromethyl)benzimidazol-1-yl]-6-morpholin-4-yl-N-[2-(1-phenylcyclopropyl)propan-2-yl]-1,3,5-triazin-2-amine (PubChem CID 157433441) has the molecular formula C115H136F8N30O5 and a molecular weight of 2170.54 g/mol. Its IUPAC name is 4-[2-(difluoromethyl)benzimidazol-1-yl]-N-[1-[2-[3-(dimethylamino)propyl]phenyl]-2-methylpropan-2-yl]-6-morpholin-4-yl-1,3,5-triazin-2-amine;4-[2-(difluoromethyl)benzimidazol-1-yl]-N-(2,3-dimethyl-3-phenylbutan-2-yl)-6-morpholin-4-yl-1,3,5-triazin-2-amine;4-[2-(difluoromethyl)benzimidazol-1-yl]-N-[2-methyl-1-[2-(1-methylpiperidin-4-yl)oxyphenyl]propan-2-yl]-6-morpholin-4-yl-1,3,5-triazin-2-amine;4-[2-(difluoromethyl)benzimidazol-1-yl]-6-morpholin-4-yl-N-[2-(1-phenylcyclopropyl)propan-2-yl]-1,3,5-triazin-2-amine.

Molecular Properties

Compound Name4-[2-(difluoromethyl)benzimidazol-1-yl]-N-[1-[2-[3-(dimethylamino)propyl]phenyl]-2-methylpropan-2-yl]-6-morpholin-4-yl-1,3,5-triazin-2-amine;4-[2-(difluoromethyl)benzimidazol-1-yl]-N-(2,3-dimethyl-3-phenylbutan-2-yl)-6-morpholin-4-yl-1,3,5-triazin-2-amine;4-[2-(difluoromethyl)benzimidazol-1-yl]-N-[2-methyl-1-[2-(1-methylpiperidin-4-yl)oxyphenyl]propan-2-yl]-6-morpholin-4-yl-1,3,5-triazin-2-amine;4-[2-(difluoromethyl)benzimidazol-1-yl]-6-morpholin-4-yl-N-[2-(1-phenylcyclopropyl)propan-2-yl]-1,3,5-triazin-2-amine
PubChem CID157433441
Molecular FormulaC115H136F8N30O5
Molecular Weight2170.54 g/mol
Exact Mass2169.12
IUPAC Name4-[2-(difluoromethyl)benzimidazol-1-yl]-N-[1-[2-[3-(dimethylamino)propyl]phenyl]-2-methylpropan-2-yl]-6-morpholin-4-yl-1,3,5-triazin-2-amine;4-[2-(difluoromethyl)benzimidazol-1-yl]-N-(2,3-dimethyl-3-phenylbutan-2-yl)-6-morpholin-4-yl-1,3,5-triazin-2-amine;4-[2-(difluoromethyl)benzimidazol-1-yl]-N-[2-methyl-1-[2-(1-methylpiperidin-4-yl)oxyphenyl]propan-2-yl]-6-morpholin-4-yl-1,3,5-triazin-2-amine;4-[2-(difluoromethyl)benzimidazol-1-yl]-6-morpholin-4-yl-N-[2-(1-phenylcyclopropyl)propan-2-yl]-1,3,5-triazin-2-amine
SMILESCC(C)(Nc1nc(N2CCOCC2)nc(-n2c(C(F)F)nc3ccccc32)n1)C(C)(C)c1ccccc1.CC(C)(Nc1nc(N2CCOCC2)nc(-n2c(C(F)F)nc3ccccc32)n1)C1(c2ccccc2)CC1.CN(C)CCCc1ccccc1CC(C)(C)Nc1nc(N2CCOCC2)nc(-n2c(C(F)F)nc3ccccc32)n1.CN1CCC(Oc2ccccc2CC(C)(C)Nc2nc(N3CCOCC3)nc(-n3c(C(F)F)nc4ccccc43)n2)CC1
InChIInChI=1S/C31H38F2N8O2.C30H38F2N8O.C27H29F2N7O.C27H31F2N7O/c1-31(2,20-21-8-4-7-11-25(21)43-22-12-14-39(3)15-13-22)38-28-35-29(40-16-18-42-19-17-40)37-30(36-28)41-24-10-6-5-9-23(24)34-27(41)26(32)33;1-30(2,20-22-11-6-5-10-21(22)12-9-15-38(3)4)37-27-34-28(39-16-18-41-19-17-39)36-29(35-27)40-24-14-8-7-13-23(24)33-26(40)25(31)32;1-26(2,27(12-13-27)18-8-4-3-5-9-18)34-23-31-24(35-14-16-37-17-15-35)33-25(32-23)36-20-11-7-6-10-19(20)30-22(36)21(28)29;1-26(2,18-10-6-5-7-11-18)27(3,4)34-23-31-24(35-14-16-37-17-15-35)33-25(32-23)36-20-13-9-8-12-19(20)30-22(36)21(28)29/h4-11,22,26H,12-20H2,1-3H3,(H,35,36,37,38);5-8,10-11,13-14,25H,9,12,15-20H2,1-4H3,(H,34,35,36,37);3-11,21H,12-17H2,1-2H3,(H,31,32,33,34);5-13,21H,14-17H2,1-4H3,(H,31,32,33,34)
InChIKeyBQUXLDOZLOHMEY-UHFFFAOYSA-N
XLogP19.86
TPSA339.67 Ų
H-Bond Donors4
H-Bond Acceptors35
Rotatable Bonds34
Heavy Atoms158
Complexity—

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5002170.54
LogP ≤ 519.86
H-Bond Donors ≤ 54
H-Bond Acceptors ≤ 1035

Analyze 4-[2-(difluoromethyl)benzimidazol-1-yl]-N-[1-[2-[3-(dimethylamino)propyl]phenyl]-2-methylpropan-2-yl]-6-morpholin-4-yl-1,3,5-triazin-2-amine;4-[2-(difluoromethyl)benzimidazol-1-yl]-N-(2,3-dimethyl-3-phenylbutan-2-yl)-6-morpholin-4-yl-1,3,5-triazin-2-amine;4-[2-(difluoromethyl)benzimidazol-1-yl]-N-[2-methyl-1-[2-(1-methylpiperidin-4-yl)oxyphenyl]propan-2-yl]-6-morpholin-4-yl-1,3,5-triazin-2-amine;4-[2-(difluoromethyl)benzimidazol-1-yl]-6-morpholin-4-yl-N-[2-(1-phenylcyclopropyl)propan-2-yl]-1,3,5-triazin-2-amine with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

N-[1-(2-cyclopentylphenyl)-2-methylpropan-2-yl]-4-[2-(difluoromethyl)benzimidazol-1-yl]-6-morpholin-4-yl-1,3,5-triazin-2-amine;4-[2-(difluoromethyl)benzimidazol-1-yl]-N-[1-[2-[3-(dimethylamino)propyl]phenyl]-2-methylpropan-2-yl]-6-morpholin-4-yl-1,3,5-triazin-2-amine;4-[2-(difluoromethyl)benzimidazol-1-yl]-N-[2-methyl-1-[2-[1-(methyl-methylidene-oxo-λ6-sulfanyl)piperidin-4-yl]phenyl]propan-2-yl]-6-morpholin-4-yl-1,3,5-triazin-2-amine;4-[2-(difluoromethyl)benzimidazol-1-yl]-N-[2-methyl-1-[2-(1-methylpyrrolidin-3-yl)phenyl]propan-2-yl]-6-morpholin-4-yl-1,3,5-triazin-2-amine;methane
CID 159934753
4-[2-(difluoromethyl)benzimidazol-1-yl]-N-[2-methyl-1-(2-methylphenyl)propan-2-yl]-6-morpholin-4-yl-1,3,5-triazin-2-amine
CID 66570855
4-[2-(difluoromethyl)benzimidazol-1-yl]-N-[2-(1-methylpiperidin-4-yl)oxypyrimidin-5-yl]-6-morpholin-4-yl-1,3,5-triazin-2-amine
CID 66854529
4-[2-(difluoromethyl)benzimidazol-1-yl]-N-[2-methyl-1-(2-piperidin-4-ylphenyl)propan-2-yl]-6-morpholin-4-yl-1,3,5-triazin-2-amine
CID 66571372
4-[2-(difluoromethyl)benzimidazol-1-yl]-N-[2-methyl-1-(2-pyridin-4-ylphenyl)propan-2-yl]-6-morpholin-4-yl-1,3,5-triazin-2-amine
CID 66571001
4-[2-(difluoromethyl)benzimidazol-1-yl]-N-[2-methyl-1-[2-[1-(methyl-methylidene-oxo-λ6-sulfanyl)piperidin-4-yl]phenyl]propan-2-yl]-6-morpholin-4-yl-1,3,5-triazin-2-amine
CID 88980679
5-N-[4-[2-(difluoromethyl)benzimidazol-1-yl]-6-morpholin-4-yl-1,3,5-triazin-2-yl]-2-N-[2-(dimethylamino)ethyl]pyridine-2,5-diamine
CID 123166656
tris(4-[2-(difluoromethyl)benzimidazol-1-yl]-N-[2-methyl-1-(4-methylphenyl)propan-2-yl]-6-morpholin-4-yl-1,3,5-triazin-2-amine);4-[2-(difluoromethyl)benzimidazol-1-yl]-N-(2-methyl-1-naphthalen-2-ylpropan-2-yl)-6-morpholin-4-yl-1,3,5-triazin-2-amine
CID 157085322
4-[2-(difluoromethyl)benzimidazol-1-yl]-N-[2-methyl-1-[2-[3-(piperidin-1-ylmethyl)phenyl]phenyl]propan-2-yl]-6-morpholin-4-yl-1,3,5-triazin-2-amine
CID 70799536
N-[1-(3-chlorophenyl)-2-methylpropan-2-yl]-4-[2-(difluoromethyl)benzimidazol-1-yl]-6-morpholin-4-yl-1,3,5-triazin-2-amine;4-[2-(difluoromethyl)benzimidazol-1-yl]-N-[1-(4-fluorophenyl)-2-methylpropan-2-yl]-6-morpholin-4-yl-1,3,5-triazin-2-amine;4-[2-(difluoromethyl)benzimidazol-1-yl]-N-[1-(2-methoxyphenyl)-2-methylpropan-2-yl]-6-morpholin-4-yl-1,3,5-triazin-2-amine;4-[2-(difluoromethyl)benzimidazol-1-yl]-N-[1-(3-methoxyphenyl)-2-methylpropan-2-yl]-6-morpholin-4-yl-1,3,5-triazin-2-amine;4-[2-(difluoromethyl)benzimidazol-1-yl]-N-[2-methyl-1-(2-methylphenyl)propan-2-yl]-6-morpholin-4-yl-1,3,5-triazin-2-amine
CID 167683410
5-N-[4-[2-(difluoromethyl)benzimidazol-1-yl]-6-morpholin-4-yl-1,3,5-triazin-2-yl]-2-N,2-N-dimethylpyridine-2,5-diamine
CID 68779056
N-[4-[[4-[2-(difluoromethyl)benzimidazol-1-yl]-6-morpholin-4-yl-1,3,5-triazin-2-yl]amino]cyclohexyl]-2-methoxyacetamide
CID 67980102

Frequently Asked Questions

What is the IUPAC name of 4-[2-(difluoromethyl)benzimidazol-1-yl]-N-[1-[2-[3-(dimethylamino)propyl]phenyl]-2-methylpropan-2-yl]-6-morpholin-4-yl-1,3,5-triazin-2-amine;4-[2-(difluoromethyl)benzimidazol-1-yl]-N-(2,3-dimethyl-3-phenylbutan-2-yl)-6-morpholin-4-yl-1,3,5-triazin-2-amine;4-[2-(difluoromethyl)benzimidazol-1-yl]-N-[2-methyl-1-[2-(1-methylpiperidin-4-yl)oxyphenyl]propan-2-yl]-6-morpholin-4-yl-1,3,5-triazin-2-amine;4-[2-(difluoromethyl)benzimidazol-1-yl]-6-morpholin-4-yl-N-[2-(1-phenylcyclopropyl)propan-2-yl]-1,3,5-triazin-2-amine?
The IUPAC name of 4-[2-(difluoromethyl)benzimidazol-1-yl]-N-[1-[2-[3-(dimethylamino)propyl]phenyl]-2-methylpropan-2-yl]-6-morpholin-4-yl-1,3,5-triazin-2-amine;4-[2-(difluoromethyl)benzimidazol-1-yl]-N-(2,3-dimethyl-3-phenylbutan-2-yl)-6-morpholin-4-yl-1,3,5-triazin-2-amine;4-[2-(difluoromethyl)benzimidazol-1-yl]-N-[2-methyl-1-[2-(1-methylpiperidin-4-yl)oxyphenyl]propan-2-yl]-6-morpholin-4-yl-1,3,5-triazin-2-amine;4-[2-(difluoromethyl)benzimidazol-1-yl]-6-morpholin-4-yl-N-[2-(1-phenylcyclopropyl)propan-2-yl]-1,3,5-triazin-2-amine (CID 157433441) is 4-[2-(difluoromethyl)benzimidazol-1-yl]-N-[1-[2-[3-(dimethylamino)propyl]phenyl]-2-methylpropan-2-yl]-6-morpholin-4-yl-1,3,5-triazin-2-amine;4-[2-(difluoromethyl)benzimidazol-1-yl]-N-(2,3-dimethyl-3-phenylbutan-2-yl)-6-morpholin-4-yl-1,3,5-triazin-2-amine;4-[2-(difluoromethyl)benzimidazol-1-yl]-N-[2-methyl-1-[2-(1-methylpiperidin-4-yl)oxyphenyl]propan-2-yl]-6-morpholin-4-yl-1,3,5-triazin-2-amine;4-[2-(difluoromethyl)benzimidazol-1-yl]-6-morpholin-4-yl-N-[2-(1-phenylcyclopropyl)propan-2-yl]-1,3,5-triazin-2-amine.
What is the SMILES notation for 4-[2-(difluoromethyl)benzimidazol-1-yl]-N-[1-[2-[3-(dimethylamino)propyl]phenyl]-2-methylpropan-2-yl]-6-morpholin-4-yl-1,3,5-triazin-2-amine;4-[2-(difluoromethyl)benzimidazol-1-yl]-N-(2,3-dimethyl-3-phenylbutan-2-yl)-6-morpholin-4-yl-1,3,5-triazin-2-amine;4-[2-(difluoromethyl)benzimidazol-1-yl]-N-[2-methyl-1-[2-(1-methylpiperidin-4-yl)oxyphenyl]propan-2-yl]-6-morpholin-4-yl-1,3,5-triazin-2-amine;4-[2-(difluoromethyl)benzimidazol-1-yl]-6-morpholin-4-yl-N-[2-(1-phenylcyclopropyl)propan-2-yl]-1,3,5-triazin-2-amine?
The canonical SMILES for 4-[2-(difluoromethyl)benzimidazol-1-yl]-N-[1-[2-[3-(dimethylamino)propyl]phenyl]-2-methylpropan-2-yl]-6-morpholin-4-yl-1,3,5-triazin-2-amine;4-[2-(difluoromethyl)benzimidazol-1-yl]-N-(2,3-dimethyl-3-phenylbutan-2-yl)-6-morpholin-4-yl-1,3,5-triazin-2-amine;4-[2-(difluoromethyl)benzimidazol-1-yl]-N-[2-methyl-1-[2-(1-methylpiperidin-4-yl)oxyphenyl]propan-2-yl]-6-morpholin-4-yl-1,3,5-triazin-2-amine;4-[2-(difluoromethyl)benzimidazol-1-yl]-6-morpholin-4-yl-N-[2-(1-phenylcyclopropyl)propan-2-yl]-1,3,5-triazin-2-amine is CC(C)(Nc1nc(N2CCOCC2)nc(-n2c(C(F)F)nc3ccccc32)n1)C(C)(C)c1ccccc1.CC(C)(Nc1nc(N2CCOCC2)nc(-n2c(C(F)F)nc3ccccc32)n1)C1(c2ccccc2)CC1.CN(C)CCCc1ccccc1CC(C)(C)Nc1nc(N2CCOCC2)nc(-n2c(C(F)F)nc3ccccc32)n1.CN1CCC(Oc2ccccc2CC(C)(C)Nc2nc(N3CCOCC3)nc(-n3c(C(F)F)nc4ccccc43)n2)CC1.
What is the InChIKey of 4-[2-(difluoromethyl)benzimidazol-1-yl]-N-[1-[2-[3-(dimethylamino)propyl]phenyl]-2-methylpropan-2-yl]-6-morpholin-4-yl-1,3,5-triazin-2-amine;4-[2-(difluoromethyl)benzimidazol-1-yl]-N-(2,3-dimethyl-3-phenylbutan-2-yl)-6-morpholin-4-yl-1,3,5-triazin-2-amine;4-[2-(difluoromethyl)benzimidazol-1-yl]-N-[2-methyl-1-[2-(1-methylpiperidin-4-yl)oxyphenyl]propan-2-yl]-6-morpholin-4-yl-1,3,5-triazin-2-amine;4-[2-(difluoromethyl)benzimidazol-1-yl]-6-morpholin-4-yl-N-[2-(1-phenylcyclopropyl)propan-2-yl]-1,3,5-triazin-2-amine?
The InChIKey is BQUXLDOZLOHMEY-UHFFFAOYSA-N. The full InChI is InChI=1S/C31H38F2N8O2.C30H38F2N8O.C27H29F2N7O.C27H31F2N7O/c1-31(2,20-21-8-4-7-11-25(21)43-22-12-14-39(3)15-13-22)38-28-35-29(40-16-18-42-19-17-40)37-30(36-28)41-24-10-6-5-9-23(24)34-27(41)26(32)33;1-30(2,20-22-11-6-5-10-21(22)12-9-15-38(3)4)37-27-34-28(39-16-18-41-19-17-39)36-29(35-27)40-24-14-8-7-13-23(24)33-26(40)25(31)32;1-26(2,27(12-13-27)18-8-4-3-5-9-18)34-23-31-24(35-14-16-37-17-15-35)33-25(32-23)36-20-11-7-6-10-19(20)30-22(36)21(28)29;1-26(2,18-10-6-5-7-11-18)27(3,4)34-23-31-24(35-14-16-37-17-15-35)33-25(32-23)36-20-13-9-8-12-19(20)30-22(36)21(28)29/h4-11,22,26H,12-20H2,1-3H3,(H,35,36,37,38);5-8,10-11,13-14,25H,9,12,15-20H2,1-4H3,(H,34,35,36,37);3-11,21H,12-17H2,1-2H3,(H,31,32,33,34);5-13,21H,14-17H2,1-4H3,(H,31,32,33,34).
What are the key properties of 4-[2-(difluoromethyl)benzimidazol-1-yl]-N-[1-[2-[3-(dimethylamino)propyl]phenyl]-2-methylpropan-2-yl]-6-morpholin-4-yl-1,3,5-triazin-2-amine;4-[2-(difluoromethyl)benzimidazol-1-yl]-N-(2,3-dimethyl-3-phenylbutan-2-yl)-6-morpholin-4-yl-1,3,5-triazin-2-amine;4-[2-(difluoromethyl)benzimidazol-1-yl]-N-[2-methyl-1-[2-(1-methylpiperidin-4-yl)oxyphenyl]propan-2-yl]-6-morpholin-4-yl-1,3,5-triazin-2-amine;4-[2-(difluoromethyl)benzimidazol-1-yl]-6-morpholin-4-yl-N-[2-(1-phenylcyclopropyl)propan-2-yl]-1,3,5-triazin-2-amine?
4-[2-(difluoromethyl)benzimidazol-1-yl]-N-[1-[2-[3-(dimethylamino)propyl]phenyl]-2-methylpropan-2-yl]-6-morpholin-4-yl-1,3,5-triazin-2-amine;4-[2-(difluoromethyl)benzimidazol-1-yl]-N-(2,3-dimethyl-3-phenylbutan-2-yl)-6-morpholin-4-yl-1,3,5-triazin-2-amine;4-[2-(difluoromethyl)benzimidazol-1-yl]-N-[2-methyl-1-[2-(1-methylpiperidin-4-yl)oxyphenyl]propan-2-yl]-6-morpholin-4-yl-1,3,5-triazin-2-amine;4-[2-(difluoromethyl)benzimidazol-1-yl]-6-morpholin-4-yl-N-[2-(1-phenylcyclopropyl)propan-2-yl]-1,3,5-triazin-2-amine has a molecular weight of 2170.54 g/mol, XLogP of 19.86, 34 rotatable bonds, 4 hydrogen bond donors, and 35 hydrogen bond acceptors.
Where does this data come from?
All data for 4-[2-(difluoromethyl)benzimidazol-1-yl]-N-[1-[2-[3-(dimethylamino)propyl]phenyl]-2-methylpropan-2-yl]-6-morpholin-4-yl-1,3,5-triazin-2-amine;4-[2-(difluoromethyl)benzimidazol-1-yl]-N-(2,3-dimethyl-3-phenylbutan-2-yl)-6-morpholin-4-yl-1,3,5-triazin-2-amine;4-[2-(difluoromethyl)benzimidazol-1-yl]-N-[2-methyl-1-[2-(1-methylpiperidin-4-yl)oxyphenyl]propan-2-yl]-6-morpholin-4-yl-1,3,5-triazin-2-amine;4-[2-(difluoromethyl)benzimidazol-1-yl]-6-morpholin-4-yl-N-[2-(1-phenylcyclopropyl)propan-2-yl]-1,3,5-triazin-2-amine is sourced from PubChem (CID 157433441), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).